CMS’ recent approval of electrophysiology ablations has sparked both excitement and concern among ASC leaders across the industry as organizations look into new and expanded outpatient cardiology ...

In the latest in our CPD series, nurse kidney specialist Gloria Munoz–Figueroa explains the principles of sustainable chronic ...

Researchers at the University of Pennsylvania have developed an AI model, CAMEL, that can forecast cardiac arrest 10–15 minutes before it occurs by analyzing extended ECG data as if it were language.

MedAxiom and AccuCode AI today announced the launch of AccuCode CV, an artificial intelligence (AI)-augmented cardiovascular ...

From heart care to no-code tools, Czechia's innovators are changing the business landscape and gaining traction beyond the ...

A UAB pathology study reveals Bmal1 as an unexpected driver of diabetic vascular calcification, linking circadian signaling ...

From sweeping CPT and ICD-10-CM code updates to new Medicare reimbursement rules, 2026 will redefine how medical coders, billers, and providers work. AI-assisted workflows, efficiency adjustments, and ...

The most successful founders of the next decade will be the ones who understand the system well enough to build the ...

Early use of hydroxychloroquine in adults with isolated discoid lupus is linked to lower 5-year rates of hyperlipidemia, coronary artery disease, and stroke, a study shows.

HeartFlow, which makes AI tools to analyze cardiac images, sued its rival Cleerly, alleging infringement on six patents. Cleerly is pushing back.

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a study conducted by DNA-testing service 23AndMe.